NCT01025063View on ClinicalTrials.gov

Use of Spectral OCT in Combination Therapy

CompletedOBSERVATIONAL

Enrollment

15

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Choroidal Neovascularization

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

Barnes Retina Institute

OTHER